MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2026-03-31.

Cash Flow Overview

Free Cash flow
$7,330K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accounts payable
    • Accrued medicaid rebates
    • Prepaid expenses and other asset...
    • Others
Negative Cash Flow Breakdown
    • Purchases of product license rig...
    • Other non-current assets and lia...
    • Accounts receivable
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net income (loss)
1,554 1,483 -1,927 -4,157
Stock-based compensation
1,518 1,124 1,092 3,296
Depreciation and amortization
1,131 1,017 1,009 2,018
Inventory step-up
350 1,421 1,324 2,349
Excess and obsolete inventory reserve
227 594 --
Debt discount amortization and non-cash interest expenses
118 175 179 342
Non-cash lease expense
9 9 5 30
Other operating activity
-7 ---
Accounts receivable
1,651 -1,325 -1,371 9,092
Inventories
-1,406 581 -5,614 10,909
Prepaid expenses and other assets
-1,754 2,521 122 -672
Accounts payable
2,508 -3,284 2,122 7,970
Accrued medicaid rebates
1,824 -8,714 1,806 9,359
Accrued liabilities
-1,532 426 1,786 -1,201
Other non-current assets and liabilities
1,818 4,025 2,233 -9,372
Acquisition of business
-0 --
Net cash from operating activities
7,405 -11,551 12,026 10,049
Purchases of product license rights
15,000 0 0 0
Purchases of property and equipment
75 49 284 0
Net cash used in investing activities
-15,075 -49 -284 0
Net proceeds from the issuance of long-term debt
-0 --
Repayment of long-term debt
-0 0 0
Common stock issued in private placement offering
-0 --
Proceeds from stock option exercises
-598 --
Payment of tax withholding related to net share settlement of stock option exercises
-0 --
Proceeds from stock option exercises
1,389 -177 0 394
Net cash from financing activities
1,389 421 0 394
Change in cash and cash equivalents
-6,281 -11,179 11,742 10,443
Cash and cash equivalents at beginning of period
25,942 37,121 14,936 -
Cash and cash equivalents at end of period
19,661 25,942 37,121 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Accounts payable$2,508K Accrued medicaidrebates$1,824K Prepaid expenses andother assets-$1,754K Net income (loss)$1,554K Proceeds from stockoption exercises$1,389K Stock-based compensation$1,518K Inventories-$1,406K Depreciation andamortization$1,131K Inventory step-up$350K Excess and obsoleteinventory reserve$227K Debt discountamortization and non-cash...$118K Non-cash lease expense$9K Other operatingactivity-$7K Net cash fromoperating activities$7,405K Net cash fromfinancing activities$1,389K Canceled cashflow$5,001K Change in cash and cashequivalents-$6,281K Canceled cashflow$8,794K Other non-currentassets and liabilities$1,818K Accounts receivable$1,651K Accrued liabilities-$1,532K Net cash used ininvesting activities-$15,075K Purchases of productlicense rights$15,000K Purchases of property andequipment$75K

Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals, Inc. (ETON)